ENOCITABINE

Enocitabine is a nucleoside analogue inhibiting DNA synthesis in cancer therapy. Side effects include myelosuppression, nausea, and mucositis.

SKU: 0819fd329a9b Category: Tag:

Product Description


Mechanism of Action

Enocitabine is a nucleoside analog structurally related to cytarabine. It is phosphorylated intracellularly to active triphosphates that inhibit DNA polymerase and terminate DNA chain elongation, impairing replication in rapidly dividing cells.

Benefits and Advantages

Used in nucleoside‑analog research, DNA‑polymerase inhibition assays, leukemia model systems, and cytotoxic‑antimetabolite pathway studies.

Side Effects and Risks

Risks include myelosuppression, GI toxicity, hepatotoxicity and neurotoxicity at high exposure. Handle with cytotoxic‑nucleoside precautions.

Datasheet


Molecular Formula

C8H11N3O4

Molecular Weight

565.8 g/mol

CAS Number

55726-47-1

Storage Condition

Store in a cool, dry place. Keep container tightly closed. Protect from moisture and light.

Solubility

Solubility depends on solvent and conditions (e.g., pH). Please contact us for solvent-specific guidance.

Purity

Purity information is available upon request (COA).

Synonym

enocitabine; 55726-47-1; Sunrabin; Enocitabina; Enocitabinum

IUPAC/Chemical Name

N-[1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-oxopyrimidin-4-yl]docosanamide

InChl Key

SAMRUMKYXPVKPA-VFKOLLTISA-N

InChl Code

InChI=1S/C31H55N3O6/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-27(36)32-26-22-23-34(31(39)33-26)30-29(38)28(37)25(24-35)40-30/h22-23,25,28-30,35,37-38H,2-21,24H2,1H3,(H,32,33,36,39)/t25-,28-,29+,30-/m1/s1

References

https://pubchem.ncbi.nlm.nih.gov/compound/71734;

3D Conformer.

(Click, turn or enlarge)

Download our GMP API Product List.

MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

Download